Literature DB >> 15699567

In situ isolation of immunoglobulin sequences expressed by single tumor-infiltrating B cells using laser-assisted microdissection.

Philippa M O'Brien1, David W M Millan, Jonathon A Davis, M Saveria Campo.   

Abstract

The isolation of fully human monoclonal antibodies (MAb) against tumor targets has to date relied largely on combinatorial library-based antibody display techniques, which generally require lengthy antigen selection procedures due to a low frequency of clones expressing compatible heavy (VH) and light chain (VL) variable genes. Here we describe a method to directly isolate immunoglobulin sequences in situ from antibody-producing cells infiltrating human tumor tissue. Single B cells and plasma cells infiltrating cervical cancer were microdissected from tissue sections using laser-assisted microscopy, and VH and VL expressed by each individual cell amplified using nested reverse transcriptase- polymerase chain reaction (RT-PCR), thus retaining the native VH and VL pairing. Sequencing analysis determined that the isolated cells expressed functional immunoglobulin variable genes, consistent with an antitumor antibody response. The immunoglobulin sequences can be reassembled as Fab or scFv fragments using conventional recombinant antibody expression plasmids. This method will allow a more direct assessment of the humoral immune response to cancer, and the potential identification of novel human therapeutic cancer antibodies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15699567     DOI: 10.1385/mb:29:2:101

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  17 in total

Review 1.  The use of recombinant antibodies in proteomics.

Authors:  L J Holt; C Enever; R M de Wildt; I M Tomlinson
Journal:  Curr Opin Biotechnol       Date:  2000-10       Impact factor: 9.740

2.  Amplification of IgG VH and VL (Fab) from single human plasma cells and B cells.

Authors:  J A Coronella; P Telleman; T D Truong; F Ylera; R P Junghans
Journal:  Nucleic Acids Res       Date:  2000-10-15       Impact factor: 16.971

Review 3.  Improving the efficacy of antibody-based cancer therapies.

Authors:  P Carter
Journal:  Nat Rev Cancer       Date:  2001-11       Impact factor: 60.716

Review 4.  The recovery of immunoglobulin sequences from single human B cells by clonal expansion.

Authors:  Ruud M T de Wildt; René M A Hoet
Journal:  Methods Mol Biol       Date:  2002

Review 5.  Engineered antibodies.

Authors:  Peter J Hudson; Christelle Souriau
Journal:  Nat Med       Date:  2003-01       Impact factor: 53.440

Review 6.  Human antibodies from combinatorial libraries.

Authors:  D R Burton; C F Barbas
Journal:  Adv Immunol       Date:  1994       Impact factor: 3.543

7.  Evidence for an antigen-driven humoral immune response in medullary ductal breast cancer.

Authors:  J A Coronella; P Telleman; G A Kingsbury; T D Truong; S Hays; R P Junghans
Journal:  Cancer Res       Date:  2001-11-01       Impact factor: 12.701

8.  Immunoglobulin genes expressed by B-lymphocytes infiltrating cervical carcinomas show evidence of antigen-driven selection.

Authors:  P M O'Brien; E Tsirimonaki; D W Coomber; D W Millan; J A Davis; M S Campo
Journal:  Cancer Immunol Immunother       Date:  2001-12       Impact factor: 6.968

Review 9.  Analysis of the B-cell repertoire against antigens expressed by human neoplasms.

Authors:  Klaus-Dieter Preuss; Carsten Zwick; Claudia Bormann; Frank Neumann; Michael Pfreundschuh
Journal:  Immunol Rev       Date:  2002-10       Impact factor: 12.988

10.  Immuno-LCM: laser capture microdissection of immunostained frozen sections for mRNA analysis.

Authors:  F Fend; M R Emmert-Buck; R Chuaqui; K Cole; J Lee; L A Liotta; M Raffeld
Journal:  Am J Pathol       Date:  1999-01       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.